Medtronic buys Physio-Control in $538 million stock swap
This article was originally published in Clinica
Medtronic is attempting to dominate the automated external defibrillator market with the acquisition of market leader, Physio-Control, in a stock swap calculated at $538 million.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?